The finding that plasma TF antigen was significantly increased in DIC as compared to non-DIC patients and healthy controls may be interpreted in favor of our conclusion that TF is an important determinant of DIC evolution in newly diagnosed AML. Here, TF is linked to acute myeloid leukemia.